POSTER SESSION III
Tuesday, March 1, 2011   —  9:30 AM - 12:00 Noon
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




DERMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
106 Expression of EZH2 and ALDH1 in Metastatic Malignant Melanoma Affects Survival. (516)
MB Queenan, J Brody, M Potoczek, A Berger, C Solomides, P McCue, AK Witkiewicz - Thomas Jefferson University Hospital, Philadelphia, PA
Add
107 Target Marker for Immunotherapy in Metastatic Melanomas of Rare Morphology Subtypes. (499)
Y-C Liu, SA Rosenberg, C-CR Lee - NCI, NIH, Bethesda, MD
Add
108 Melanoma of Unknown Primary Origin: Decreased Survival for Stage 4 Patients. (518)
EC Rushing, R Tuthill - The Cleveland Clinic Foundation, OH
Add
109 Significance of Sentinel Lymph Node Isolated Tumor Cell Clusters in Overall Survival of Melanoma Patients. (528)
JG Vincent, JA Wisell, JD Cuda, AT Hillel, WH Westra, JM Taube - The Johns Hopkins Hospital, Baltimore, MD; The University of Colorado, Denver; Stanford University, Palo Alto, CA
Add
110 Sentinel Lymph Node Biopsies in Melanoma: A Retrospective Review of Outcomes and Tumor Burden. (481)
P Fong, WR Porter, MB Amin, R Keiden, RK Malhotra - William Beaumont Hospital, Royal Oak, MI
Add
111 Lymphatic Invasion in Melanocytic Tumors of Uncertain Malignant Potential May Predict Worse Outcomes. (463)
RM Abraham, DE Elder, L Cerroni, M Mihm, X Xu - University of Pennsylvania, Philadelphia; Medical University of Graz, Austria; Harvard Medical School, Boston, MA
Add
112 Differential Diagnosis of Melanomas Using Fluorescence In Situ Hybridization (FISH) . MelanoFISH. (488)
D Hossain, J Qian, J Adupe, K Drewnowska, S Varvel, MM Wilk, DG Bostwick - Bostwick Laboratories, Glen Allen, VA
Add
113 Evaluation of Proliferation Index by Ki-67 and ProEx-C in Malignant Melanoma and Benign Melanocytic Nevi. (473)
BN Coffing, S Yan - Dartmouth Hitchcock Medical Center, Lebanon, NH
Add
114 Epigenetics Markers in Acral Lentiginous/Mucosal Melanoma: Expression of EZH2. (497)
EM Li-Ning-Tapia, J Curry, P Zhang, VG Prieto, CA Torres-Cabala - UT-MD Anderson Cancer Center, Houston, TX
Add
115 Clinicopathologic, Immunohistochemical and Molecular Analysis in the Differential Diagnosis of Reed Nevus and Spindle Cell Melanoma. (476)
A Diaz, S Hakim, A Valera, A Garcia, C Carrera, J Palou, S Puig, J Malvehy, L Alos - Hospital Clinic, University of Barcelona, Spain
Add
116 Tyrosinase-Related Protein2 (trp2) Is a Melanocyte Differentiation Antigen (MDA) Useful for Surgical Pathology. (465)
F Avogadri, J Tassello, D Frosina, N Hanson, M Holz, E Ritter, T Mehgroub, KJ Busam, AA Jungbluth - Memorial Sloan-Kettering Cancer Center, New York, NY
Add
117 Transplant Melanoma: An Emerging Recipient Risk. (519)
EC Rushing, V Krishnamurthi, C Farver, R Tuthill - The Cleveland Clinic Foundation, OH
Add
118 Definition and Categorization of Combined Melanocytic Nevi. (466)
JL Baran, LM Duncan - Massachusetts General Hospital, Boston
Add
119 Utility of SOX10 as a Reliable Marker for Melanocytes in Sun-Damaged Skin. (506)
K Ojemakinde, P Adegboyega - LSU Health Sciences Center, Shreveport, LA
Add
120 GNAQ Gene Status in Cellular Blue Nevi, Spitzoid and Spindle Cell Melanomas. (529)
S Vullaganti, P DeVilliers, T Isayeva, A Andea - University of Alabama at Birmingham
Add
121 Angiotropism in Congenital Melanocytic Nevi: Clinicopathological Study of 56 Cases. (494)
VB Kokta, R Al Dhaybi, RL Barnhill - CHU Sainte-Justine, Montreal, QC, Canada; Universite de Paris Diderot, France
Add
122 KIT in Atypical Acral Nevi . An Immunohistochemical and Genetic Appraisal. (509)
E Park, S Yang, A Emley, K DeCarlo, J Richards, M Mahalingam - Boston University School of Medicine, MA
Add
123 Proliferative Nodule Arising within Congenital Melanocytic Nevus: Histologic, Immunohistochemical and Molecular Analyses of 43 Cases. (511)
PA Phadke, D Rakheja, LP Le, MA Selim, P Kapur, A Davis, MC Mihm, MP Hoang - Massachusetts General Hospital/Harvard Medical School, Boston; University of Texas Southwestern Medical Center, Dallas; Duke University Medical Center, Durham, NC
Add
124 Distinctive Eosinophilic Cytoplasmic Inclusion Bodies in Melanocytic Nevi: An Immunohistochemical and Ultrastructural Study. (522)
W Shon, DA Wada, LE Gibson, TJ Flotte, BW Scheithauer - Mayo Clinic, Rochester, MN
Add